These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 16878941)
61. Insights into the molecular mechanisms of protein platination from a case study: the reaction of anticancer platinum(II) iminoethers with horse heart cytochrome c. Casini A; Gabbiani C; Mastrobuoni G; Pellicani RZ; Intini FP; Arnesano F; Natile G; Moneti G; Francese S; Messori L Biochemistry; 2007 Oct; 46(43):12220-30. PubMed ID: 17924668 [TBL] [Abstract][Full Text] [Related]
62. Quantum chemical modeling of the reduction of cis-diammineplatinum(IV) tetrachloride [Pt(NH3)2Cl4] by methyl thiolate anion. Dobrogorskaia-Méreau IaI; Nemukhin AV J Comput Chem; 2005 Jul; 26(9):865-70. PubMed ID: 15825188 [TBL] [Abstract][Full Text] [Related]
63. Platinum complexes of diazo ligands. Studies of regioselective aromatic ring amination, oxidative halogen addition and reductive halogen elimination reactions. Panda M; Das S; Mostafa G; Castineiras A; Goswami S Dalton Trans; 2005 Apr; (7):1249-55. PubMed ID: 15782261 [TBL] [Abstract][Full Text] [Related]
64. Reactivity of ammonia ligands of the antitumor agent cisplatin: a unique dodecanuclear Pt4,Pd4,Ag4 platform for four cytosine model nucleobases. Kampf G; Sanz Miguel PJ; Morell Cerdà M; Willermann M; Schneider A; Lippert B Chemistry; 2008; 14(23):6882-91. PubMed ID: 18576415 [TBL] [Abstract][Full Text] [Related]
65. Mass spectrometric studies of the formation and reactivity of trans-[PtCl2(Am)(piperidinopiperidine)] x HCl complexes with ubiquitin. Balter L; Gibson D Rapid Commun Mass Spectrom; 2005; 19(24):3666-72. PubMed ID: 16285018 [TBL] [Abstract][Full Text] [Related]
68. Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance. Margiotta N; Natile G; Capitelli F; Fanizzi FP; Boccarelli A; De Rinaldis P; Giordano D; Coluccia M J Inorg Biochem; 2006 Nov; 100(11):1849-57. PubMed ID: 16959321 [TBL] [Abstract][Full Text] [Related]
69. Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands. Knipp M; Karotki AV; Chesnov S; Natile G; Sadler PJ; Brabec V; Vasák M J Med Chem; 2007 Aug; 50(17):4075-86. PubMed ID: 17665893 [TBL] [Abstract][Full Text] [Related]
70. The crystal structure of a novel Pt(II) complex with 2-hydroxy-6-methylpyridine (Hmhp), trans-[PtCl2(dmso)(Hmhp)]·H2O. Grabner S; Bukovec P Acta Chim Slov; 2015; 62(2):389-93. PubMed ID: 26085422 [TBL] [Abstract][Full Text] [Related]
71. Cisplatin mediates selective downstream hydrolytic cleavage of Met-(Gly)(n)-His segments (n=1,2) in methionine- and histidine-containing peptides: the role of ammine loss trans to the initial Pt-S(Met) anchor in facilitating amide hydrolysis. Hohage O; Sheldrick WS J Inorg Biochem; 2006 Sep; 100(9):1506-13. PubMed ID: 16806482 [TBL] [Abstract][Full Text] [Related]
72. Relationships between reduction properties and cancer cell growth inhibitory activities of cis-dichloro- and cis-diiodo-Pt(IV)-ethylenediamines. Kratochwil NA; Bednarski PJ Arch Pharm (Weinheim); 1999 Aug; 332(8):279-85. PubMed ID: 10489538 [TBL] [Abstract][Full Text] [Related]
73. Chemical and cellular investigations of trans-ammine-pyridine-dichlorido-platinum(II), the likely metabolite of the antitumor active cis-diammine-pyridine-chorido-platinum(II). Xu D; Min Y; Cheng Q; Shi H; Wei K; Arnesano F; Natile G; Liu Y J Inorg Biochem; 2013 Dec; 129():15-22. PubMed ID: 24008133 [TBL] [Abstract][Full Text] [Related]
74. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds. Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329 [TBL] [Abstract][Full Text] [Related]
75. Probing platinum azido complexes by 14N and 15N NMR spectroscopy. Farrer NJ; Gierth P; Sadler PJ Chemistry; 2011 Oct; 17(43):12059-66. PubMed ID: 21922574 [TBL] [Abstract][Full Text] [Related]
76. Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand. Najajreh Y; Kasparkova J; Marini V; Gibson D; Brabec V J Biol Inorg Chem; 2005 Nov; 10(7):722-31. PubMed ID: 16208494 [TBL] [Abstract][Full Text] [Related]
77. [1H, 15N] heteronuclear single quantum coherence NMR study of the mechanism of aquation of platinum(IV) ammine complexes. Davies MS; Hall MD; Berners-Price SJ; Hambley TW Inorg Chem; 2008 Sep; 47(17):7673-80. PubMed ID: 18671390 [TBL] [Abstract][Full Text] [Related]
78. Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine. Halámiková A; Heringová P; Kaspárková J; Intini FP; Natile G; Nemirovski A; Gibson D; Brabec V J Inorg Biochem; 2008; 102(5-6):1077-89. PubMed ID: 18237783 [TBL] [Abstract][Full Text] [Related]
79. Reaction of cis- and trans-[PtCl2(NH3)2] with reduced glutathione inside human red blood cells, studied by 1H and 15N-[1H] DEPT NMR. Berners-Price SJ; Kuchel PW J Inorg Biochem; 1990 Apr; 38(4):327-45. PubMed ID: 2332767 [TBL] [Abstract][Full Text] [Related]
80. Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands. Zorbas-Seifried S; Jakupec MA; Kukushkin NV; Groessl M; Hartinger CG; Semenova O; Zorbas H; Kukushkin VY; Keppler BK Mol Pharmacol; 2007 Jan; 71(1):357-65. PubMed ID: 17050805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]